THC TENET HEALTHCARE CORP
Services-General Medical & Surgical Hospitals, NEC · NYSE · SEC CIK 70318 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY6.2%
TTM net income YoY114.1%
TTM EPS YoY133.1%
Revenue 3-yr CAGR3.2%
Net income 3-yr CAGR83.5%
Margins
Gross margin—
Operating margin24.4%
Net margin13.1%
FCF margin15.0%
EBITDA margin28.4%
Returns
ROE61.3%
ROA9.5%
ROIC (approx.)28.2%
Asset turnover0.73x
Leverage & solvency
Liabilities / assets69.6%
Debt / equity2.43x
Current ratio1.58x
Interest coverage6.61x
Cash quality & payout
Operating cash flow / net income1.46x
Accruals ratio-4.4%
Payout ratio—
Capex / revenue4.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY2025*2025-12-31 | FY2024*2024-12-31 | FY2023*2023-12-31 | FY2022*2022-12-31 | FY2021*2021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $21.31B | $20.68B | $20.56B | $19.17B | $19.48B |
| Operating income | $3.51B | $5.96B | $2.51B | $2.33B | $2.87B |
| Interest expense | $821.00M | $826.00M | $901.00M | $890.00M | $923.00M |
| Pretax income | $2.80B | $5.25B | $1.62B | $1.34B | $1.89B |
| Income tax | $433.00M | $1.18B | $306.00M | $344.00M | $411.00M |
| Net income | $1.41B | $3.20B | $611.00M | $411.00M | $914.00M |
| EBITDA | $4.37B | $6.77B | $3.38B | $3.17B | $3.73B |
| EPS (basic) | 15.61 | 33.02 | 6.01 | 3.84 | 8.55 |
| EPS (diluted) | 15.49 | 32.70 | 5.71 | 3.79 | 8.42 |
| Weighted avg. shares (diluted) | 90.83M | 97.88M | 104.80M | 110.52M | 108.57M |
| Balance sheet | |||||
| Cash & equivalents | $2.88B | $3.02B | $1.23B | $858.00M | $2.36B |
| Receivables | $2.56B | $2.54B | $2.91B | $2.94B | $2.77B |
| Inventory | $348.00M | $346.00M | $411.00M | $405.00M | $384.00M |
| Current assets | $7.85B | $7.68B | $7.17B | $5.98B | $7.08B |
| PP&E, net | $6.32B | $6.05B | $6.24B | $6.46B | $6.43B |
| Goodwill | $11.20B | $10.69B | $10.31B | $10.12B | $9.26B |
| Intangibles | $1.35B | $1.40B | $1.37B | $1.42B | $1.50B |
| Total assets | $29.68B | $28.94B | $28.31B | $27.16B | $27.58B |
| Current liabilities | $4.46B | $4.31B | $4.76B | $4.48B | $5.11B |
| Short-term debt | $79.00M | $92.00M | $120.00M | $145.00M | $135.00M |
| Long-term debt | $13.09B | $13.08B | $14.88B | $14.93B | $15.51B |
| Total debt | $13.17B | $13.17B | $15.00B | $15.08B | $15.65B |
| Total liabilities | $20.70B | $20.39B | $22.80B | $22.55B | $23.32B |
| Shareholders' equity | $4.22B | $4.17B | $1.61B | $1.14B | $1.03B |
| Net debt | $10.29B | $10.15B | $13.77B | $14.22B | $13.28B |
| Cash flow statement | |||||
| Operating cash flow | $3.54B | $2.05B | $2.37B | $1.08B | $1.57B |
| Capital expenditure | $1.01B | $931.00M | $751.00M | $762.00M | $658.00M |
| Free cash flow | $2.53B | $1.12B | $1.62B | $321.00M | $910.00M |
| Investing cash flow | -$1.27B | $3.43B | -$969.00M | -$808.00M | -$714.00M |
| Financing cash flow | -$2.40B | -$3.69B | -$1.03B | -$1.78B | -$936.00M |
| Depreciation & amortization | $863.00M | $818.00M | $870.00M | $841.00M | $855.00M |
| Stock-based compensation | $104.00M | $67.00M | $66.00M | $56.00M | $56.00M |
| Share buybacks | $1.39B | $672.00M | $200.00M | $250.00M | $0 |
Free plan shows the latest 5 periods; Pro shows all 18 🔒
· This company does not report gross profit in XBRL.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.